{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:19Z","timestamp":1791859279916,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["23680420"],"award-info":[{"award-number":["23680420"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12375880"],"award-info":[{"award-number":["PNRR-MR1-2022-12375880"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06203-0","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:09:51Z","timestamp":1740042591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Omics data integration analysis identified new biological insights into chronic antibody-mediated rejection (CAMR)"],"prefix":"10.1186","volume":"23","author":[{"given":"Maurizio","family":"Bruschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Candiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pontrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Petretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-6196","authenticated-orcid":false,"given":"Gianluigi","family":"Zaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"12","key":"6203_CR1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1056\/NEJMra1802677","volume":"379","author":"A Loupy","year":"2018","unstructured":"Loupy A, Lefaucheur C. Antibody-mediated rejection of solid-organ allografts. N Engl J Med. 2018;379(12):1150.","journal-title":"N Engl J Med"},{"issue":"2","key":"6203_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"J Sellar\u00e9s","year":"2012","unstructured":"Sellar\u00e9s J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transpl. 2012;12(2):388\u201399.","journal-title":"Am J Transpl"},{"issue":"7","key":"6203_CR3","doi-asserted-by":"publisher","first-page":"e14320","DOI":"10.1111\/ctr.14320","volume":"35","author":"A Hart","year":"2021","unstructured":"Hart A, Singh D, Brown SJ, Wang JH, Kasiske BL. Incidence, risk factors, treatment, and consequences of antibody-mediated kidney transplant rejection: a systematic review. Clin Transpl. 2021;35(7):e14320.","journal-title":"Clin Transpl"},{"issue":"6","key":"6203_CR4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/ajt.15177","volume":"19","author":"C Wiebe","year":"2019","unstructured":"Wiebe C, Kosmoliaptsis V, Pochinco D, Gibson IW, Ho J, Birk PE, Goldberg A, Karpinski M, Shaw J, Rush DN, Nickerson PW. HLA-DR\/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity. Am J Transpl. 2019;19(6):1708\u201319.","journal-title":"Am J Transpl"},{"key":"6203_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12979-019-0149-8","volume":"16","author":"S von Moos","year":"2019","unstructured":"von Moos S, Schalk G, Mueller TF, Laube G. Age-associated decrease in de novo donor-specific antibodies in renal transplant recipients reflects changing humoral immunity. Immun Ageing. 2019;16:9.","journal-title":"Immun Ageing"},{"key":"6203_CR6","doi-asserted-by":"publisher","first-page":"943502","DOI":"10.3389\/fmed.2022.943502","volume":"9","author":"C Del L\u00f3pez","year":"2022","unstructured":"Del L\u00f3pez C, Wu K, Naik M, Osmanodja B, Akifova A, Lachmann N, Stauch D, Hergovits S, Choi M, Bachmann F, Halleck F, Schrezenmeier E, Schmidt D, Budde K. The natural history of de novo donor-specific HLA antibodies after kidney transplantation. Front Med (Lausanne). 2022;9:943502.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"6203_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/TP.0000000000000448","volume":"99","author":"JM Chemouny","year":"2015","unstructured":"Chemouny JM, Suberbielle C, Rabant M, Zuber J, Alyanakian MA, Lebreton X, Carmagnat M, Pinheiro N, Loupy A, Van Huyen JP, Timsit MO, Charron D, Legendre C, Anglicheau D. De Novo Donor-Specific Human Leukocyte Antigen Antibodies in nonsensitized kidney transplant recipients after T cell-mediated rejection. Transplantation. 2015;99(5):965\u201372.","journal-title":"Transplantation"},{"issue":"5","key":"6203_CR8","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/ajt.15754","volume":"20","author":"SS Wan","year":"2020","unstructured":"Wan SS, Chadban SJ, Watson N, Wyburn K. Development and outcomes of de novo donor-specific antibodies in low, moderate, and high immunological risk kidney transplant recipients. Am J Transpl. 2020;20(5):1351\u201364.","journal-title":"Am J Transpl"},{"issue":"12","key":"6203_CR9","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1111\/ajt.14393","volume":"17","author":"N Lachmann","year":"2017","unstructured":"Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F, Pru\u00df A, Sch\u00f6nemann C, Spierings E, Staeck O. Donor-recipient matching based on predicted indirectly recognizable HLA epitopes independently predicts the incidence of De Novo Donor-specific HLA antibodies following renal transplantation. Am J Transpl. 2017;17(12):3076\u201386.","journal-title":"Am J Transpl"},{"issue":"1","key":"6203_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.4553","volume":"237","author":"F Rascio","year":"2015","unstructured":"Rascio F, Pontrelli P, Accetturo M, Oranger A, Gigante M, Castellano G, Gigante M, Zito A, Zaza G, Lupo A, Ranieri E, Stallone G, Gesualdo L, Grandaliano G. A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. J Pathol. 2015;237(1):72\u201384.","journal-title":"J Pathol"},{"issue":"18","key":"6203_CR11","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.3390\/ijms21186509","volume":"21","author":"MT Rocchetti","year":"2020","unstructured":"Rocchetti MT, Rascio F, Castellano G, Fiorentino M, Netti GS, Spadaccino F, Ranieri E, Gallone A, Gesualdo L, Stallone G, Pontrelli P, Grandaliano G. Altered phosphorylation of Cytoskeleton Proteins in Peripheral Blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation. Int J Mol Sci. 2020;21(18):6509.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6203_CR12","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.ekir.2022.09.025","volume":"7","author":"P Cravedi","year":"2022","unstructured":"Cravedi P, Bruschi M, Pontrelli P, Grandaliano G, Zaza G, Fribourg M. Increased complement gene expression in circulating B cells from kidney transplant recipients with chronic antibody-mediated rejection. Kidney Int Rep. 2022;7(12):2752\u20133.","journal-title":"Kidney Int Rep"},{"key":"6203_CR13","doi-asserted-by":"publisher","first-page":"767618","DOI":"10.3389\/fimmu.2021.767618","volume":"12","author":"F Kong","year":"2022","unstructured":"Kong F, Ye S, Zhong Z, Zhou X, Zhou W, Liu Z, Lan J, Xiong Y, Ye Q. Single-cell transcriptome analysis of chronic antibody-mediated rejection after renal transplantation. Front Immunol. 2022;12:767618.","journal-title":"Front Immunol"},{"issue":"1","key":"6203_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12967-021-03025-8","volume":"19","author":"Y Lin","year":"2021","unstructured":"Lin Y, Wang L, Ge W, Hui Y, Zhou Z, Hu L, Pan H, Huang Y, Shen B. Multi-omics network characterization reveals novel microRNA biomarkers and mechanisms for diagnosis and subtyping of kidney transplant rejection. J Transl Med. 2021;19(1):346.","journal-title":"J Transl Med"},{"issue":"4","key":"6203_CR15","doi-asserted-by":"publisher","first-page":"e60702","DOI":"10.1371\/journal.pone.0060702","volume":"8","author":"R Danger","year":"2013","unstructured":"Danger R, Paul C, Giral M, Lavault A, Foucher Y, Degauque N, Pallier A, Durand M, Castagnet S, Van Duong JP, Delahousse M, Renaudin K, Soulillou JP, Brouard S. Expression of mir-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS ONE. 2013;8(4):e60702.","journal-title":"PLoS ONE"},{"issue":"9","key":"6203_CR16","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/ajt.15898","volume":"20","author":"A Loupy","year":"2020","unstructured":"Loupy A, Haas M, Roufosse C, Naesens M, Adam B, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell LD, Clahsen-van Groningen MC, Demetris AJ, Dragun D, van Duong JP, Farris AB, Fogo AB, Gibson IW, Glotz D, Gueguen J, Kikic Z, Kozakowski N, Kraus E, Lefaucheur C, Liapis H, Mannon RB, Montgomery RA, Nankivell BJ, Nickeleit V, Nickerson P, Rabant M, Racusen L, Randhawa P, Robin B, Rosales IA, Sapir-Pichhadze R, Schinstock CA, Seron D, Singh HK, Smith RN, Stegall MD, Zeevi A, Solez K, Colvin RB, Mengel M. The Banff 2019 kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transpl. 2020;20(9):2318\u201331.","journal-title":"Am J Transpl"},{"issue":"11","key":"6203_CR17","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1021\/acs.jproteome.7b00418","volume":"16","author":"J Forshed","year":"2017","unstructured":"Forshed J. Experimental design in clinical \u2018Omics Biomarker Discovery. J Proteome Res. 2017;16(11):3954\u201360.","journal-title":"J Proteome Res"},{"issue":"4","key":"6203_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1074\/mcp.TIR119.001906","volume":"19","author":"DB Bekker-Jensen","year":"2020","unstructured":"Bekker-Jensen DB, Mart\u00ednez-Val A, Steigerwald S, R\u00fcther P, Fort KL, Arrey TN, Harder A, Makarov A, Olsen JV. A Compact quadrupole-orbitrap Mass Spectrometer with FAIMS Interface improves Proteome Coverage in short LC gradients. Mol Cell Proteom. 2020;19(4):716\u201329.","journal-title":"Mol Cell Proteom"},{"issue":"5","key":"6203_CR19","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer R, Bernhardt OM, Gandhi T, Miladinovi\u0107 SM, Cheng LY, Messner S, Ehrenberger T, Zanotelli V, Butscheid Y, Escher C, Vitek O, Rinner O, Reiter L. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteom. 2015;14(5):1400\u201310.","journal-title":"Mol Cell Proteom"},{"issue":"3","key":"6203_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","volume":"2","author":"PE Geyer","year":"2016","unstructured":"Geyer PE, Kulak NA, Pichler G, Holdt LM, Teupser D, Mann M. Plasma proteome profiling to assess Human Health and Disease. Cell Syst. 2016;2(3):185\u201395.","journal-title":"Cell Syst"},{"issue":"8","key":"6203_CR21","doi-asserted-by":"publisher","first-page":"e14167","DOI":"10.15252\/emmm.202114167","volume":"13","author":"PE Geyer","year":"2021","unstructured":"Geyer PE, Arend FM, Doll S, Louiset ML, Virreira Winter S, M\u00fcller-Reif JB, Torun FM, Weigand M, Eichhorn P, Bruegel M, Strauss MT, Holdt LM, Mann M, Teupser D. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion. EMBO Mol Med. 2021;13(8):e14167.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"6203_CR22","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s42003-024-06370-8","volume":"7","author":"U Nygaard","year":"2024","unstructured":"Nygaard U, Nielsen AB, Dungu KHS, Drici L, Holm M, Ottenheijm ME, Nielsen AB, Glenth\u00f8j JP, Schmidt LS, Cortes D, J\u00f8rgensen IM, Mogensen TH, Schmiegelow K, Mann M, Vissing NH, Wewer Albrechtsen NJ. Proteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem inflammatory syndrome in children. Commun Biol. 2024;7(1):688.","journal-title":"Commun Biol"},{"issue":"3","key":"6203_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","volume":"12","author":"M Mengel","year":"2012","unstructured":"Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D. Banff meeting report writing committee. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transpl. 2012;12(3):563\u201370.","journal-title":"Am J Transpl"},{"key":"6203_CR24","unstructured":"R Core Team. (2021) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna. Available from https:\/\/www.R-project.org"},{"issue":"1","key":"6203_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/ajt.14979","volume":"19","author":"CA Schinstock","year":"2019","unstructured":"Schinstock CA, Sapir-Pichhadze R, Naesens M, Batal I, Bagnasco S, Bow L, Campbell P, Clahsen-van Groningen MC, Cooper M, Cozzi E, Dadhania D, Diekmann F, Budde K, Lower F, Orandi BJ, Rowshani AT, Cornell L, Kraus E. Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: diagnostic misinterpretation has potential therapeutic implications. Am J Transpl. 2019;19(1):123\u201331.","journal-title":"Am J Transpl"},{"key":"6203_CR26","doi-asserted-by":"crossref","unstructured":"Gupta G, Athreya A, Kataria A. Biomarkers in Kidney Transplantation: A Rapidly Evolving Landscape. Transplantation. 2024 Jul 18.","DOI":"10.1097\/TP.0000000000005122"},{"issue":"7","key":"6203_CR27","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1681\/ASN.2016091034","volume":"28","author":"RD Bloom","year":"2017","unstructured":"Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, Matas AJ, Mehta S, Mannon RB, Sharfuddin A, Fischbach B, Narayanan M, Jordan SC, Cohen D, Weir MR, Hiller D, Prasad P, Woodward RN, Grskovic M, Sninsky JJ, Yee JP, Brennan DC. Circulating donor-derived cell-free DNA in blood for diagnosing active rejection in kidney transplant recipients (DART) study investigators. Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol. 2017;28(7):2221\u201332.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"6203_CR28","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1111\/ajt.15416","volume":"19","author":"M Oellerich","year":"2019","unstructured":"Oellerich M, Shipkova M, Asendorf T, Walson PD, Schauerte V, Mettenmeyer N, Kabakchiev M, Hasche G, Gr\u00f6ne HJ, Friede T, Wieland E, Schwenger V, Sch\u00fctz E, Beck J. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study. Am J Transpl. 2019;19(11):3087\u201399.","journal-title":"Am J Transpl"},{"issue":"3","key":"6203_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/TP.0000000000004324","volume":"107","author":"PF Halloran","year":"2023","unstructured":"Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Gauthier P, Billings P, Lawrence C, Lowe D, Hidalgo LG. The Trifecta investigators. Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: results from the Trifecta Study. Transplantation. 2023;107(3):709\u201319.","journal-title":"Transplantation"},{"key":"6203_CR30","doi-asserted-by":"crossref","unstructured":"Akifova A, Budde K, Amann K, Buettner-Herold M, Choi M, Oellerich M, Beck J, Bornemann-Kolatzki K, Sch\u00fctz E, Bachmann F, Halleck F, von Hoerschelmann E, Koch N, Schrezenmeier E, Seelow E, Waiser J, Zukunft B, Eckardt KU, Halbritter J, Kettritz R, Del Moral CL, Lachmann N, Stauch D, Niemann M, Schmidt D, Halloran PF, Osmanodja B. Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial. Nephrol Dial Transpl. 2024 Nov;29:gfae282.","DOI":"10.1093\/ndt\/gfae282"},{"issue":"4","key":"6203_CR31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1681\/ASN.2020060850","volume":"32","author":"R El Fekih","year":"2021","unstructured":"El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C, Choi J, Allos H, Yatim K, Alhaddad J, Eskandari S, Chu P, Mihali AB, Lape IT, Lima Filho MP, Aoyama BT, Chandraker A, Safa K, Markmann JF, Riella LV, Formica RN, Skog J, Azzi JR. Discovery and Validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection. J Am Soc Nephrol. 2021;32(4):994\u20131004.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"6203_CR32","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1097\/TP.0000000000002141","volume":"102","author":"E Velidedeoglu","year":"2018","unstructured":"Velidedeoglu E, Cavaill\u00e9-Coll MW, Bala S, Belen OA, Wang Y, Albrecht R. Summary of 2017 FDA Public Workshop: antibody-mediated rejection in kidney transplantation. Transplantation. 2018;102(6):e257\u201364.","journal-title":"Transplantation"},{"issue":"5","key":"6203_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/TP.0000000000003095","volume":"104","author":"CA Schinstock","year":"2020","unstructured":"Schinstock CA, Mannon RB, Budde K, Chong AS, Haas M, Knechtle S, Lefaucheur C, Montgomery RA, Nickerson P, Tullius SG, Ahn C, Askar M, Crespo M, Chadban SJ, Feng S, Jordan SC, Man K, Mengel M, Morris RE, O\u2019Doherty I, Ozdemir BH, Seron D, Tambur AR, Tanabe K, Taupin JL. O\u2019Connell PJ. Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 Expert Consensus from the Transplantion Society Working Group. Transplantation. 2020;104(5):911\u201322.","journal-title":"Transplantation"},{"issue":"1","key":"6203_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","volume":"5","author":"T Zhao","year":"2020","unstructured":"Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5(1):201.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"6203_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/ph17030307","volume":"17","author":"MC Chang","year":"2024","unstructured":"Chang MC, Chen CT, Chiang PF, Chiang YC. The role of Chitinase-3-like Protein-1 (YKL40) in the therapy of Cancer and other chronic-inflammation-related diseases. Pharmaceuticals (Basel). 2024;17(3):307.","journal-title":"Pharmaceuticals (Basel)"},{"key":"6203_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","volume":"73","author":"CG Lee","year":"2011","unstructured":"Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA. Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479\u2013501.","journal-title":"Annu Rev Physiol"},{"key":"6203_CR37","doi-asserted-by":"crossref","unstructured":"Kjaergaard AD, Helby J, Johansen JS, Nordestgaard BG, Bojesen SE. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population. Clin Microbiol Infect. 2020;26(10):1411.e1-1411.e9.","DOI":"10.1016\/j.cmi.2020.01.010"},{"issue":"11","key":"6203_CR38","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1080\/15384101.2020.1750811","volume":"19","author":"Y Sun","year":"2020","unstructured":"Sun Y, Shi Z, Liu B, Li X, Li G, Yang F, Tang H. YKL-40 mediates airway remodeling in asthma via activating FAK and MAPK signaling pathway. Cell Cycle. 2020;19(11):1378\u201390.","journal-title":"Cell Cycle"},{"issue":"12","key":"6203_CR39","first-page":"1585","volume":"19","author":"TK Chen","year":"2024","unstructured":"Chen TK, Estrella MM, Katz R, Sarnak MJ, Grams ME, Cushman M, Levitan EB, Parikh CR, Kimmel PL, Bonventre JV, Coca SG, Guti\u00e9rrez OM, Ix JH, Shlipak MG. Plasma Biomarkers of Kidney Health and mortality in diabetes and chronic kidney disease in the REGARDS Study. Clin J Am Soc Nephrol. 2024;19(12):1585\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"key":"6203_CR40","doi-asserted-by":"publisher","first-page":"35282","DOI":"10.1038\/srep35282","volume":"6","author":"E Kumagai","year":"2016","unstructured":"Kumagai E, Mano Y, Yoshio S, Shoji H, Sugiyama M, Korenaga M, Ishida T, Arai T, Itokawa N, Atsukawa M, Hyogo H, Chayama K, Ohashi T, Ito K, Yoneda M, Kawaguchi T, Torimura T, Nozaki Y, Watanabe S, Mizokami M, Kanto T. Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep. 2016;6:35282.","journal-title":"Sci Rep"},{"issue":"5","key":"6203_CR41","doi-asserted-by":"publisher","first-page":"e014634","DOI":"10.1161\/JAHA.119.014634","volume":"9","author":"J Schroder","year":"2020","unstructured":"Schroder J, Jakobsen JC, Winkel P, Hilden J, Jensen GB, Sajadieh A, Larsson A, \u00c4rnl\u00f6v J, Harutyunyan M, Johansen JS, Kj\u00f8ller E, Gluud C, Kastrup J. Prognosis and reclassification by YKL-40 in stable coronary artery disease. J Am Heart Assoc. 2020;9(5):e014634.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"6203_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5551\/jat.26385","volume":"22","author":"I Kocyigit","year":"2015","unstructured":"Kocyigit I, Gungor O, Dogan E, Karadavut S, Karakukcu C, Eroglu E, Orscelik O, Unal A, Dogan A, Sipahioglu MH, Tokgoz B, Oymak O. The serum YKL-40 level is associated with vascular injury and predicts proteinuria in nephrotic syndrome patients. J Atheroscler Thromb. 2015;22(3):257\u201364.","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"6203_CR43","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.transproceed.2014.09.017","volume":"46","author":"J Malyszko","year":"2014","unstructured":"Malyszko J, Koc-Zorawska E, Malyszko J. YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients. Transpl Proc. 2014;46(8):2651\u20133.","journal-title":"Transpl Proc"},{"key":"6203_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.12659\/AOT.883844","volume":"18","author":"E Tatar","year":"2013","unstructured":"Tatar E, Gungor O, Celtik A, Sisman AR, Yaprak M, Asci G, Ozkahya M, Toz H. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients. Ann Transpl. 2013;18:95\u2013100.","journal-title":"Ann Transpl"},{"issue":"3","key":"6203_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2215\/CJN.02780319","volume":"15","author":"R Malhotra","year":"2020","unstructured":"Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W, Rastogi A, Cheung AK, Freedman BI, Punzi H, Rocco MV, Ix JH, Shlipak MG. Urine markers of kidney Tubule Cell Injury and kidney function decline in SPRINT Trial participants with CKD. Clin J Am Soc Nephrol. 2020;15(3):349\u201358.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"6203_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11255-019-02364-2","volume":"52","author":"ES Albeltagy","year":"2020","unstructured":"Albeltagy ES, Abdul-Mohymen AM, Taha DRA. Early diagnosis of acute kidney injury by urinary YKL-40 in critically ill patients in ICU: a pilot study. Int Urol Nephrol. 2020;52(2):351\u201361.","journal-title":"Int Urol Nephrol"},{"key":"6203_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13054-016-1192-x","volume":"20","author":"J De Loor","year":"2016","unstructured":"De Loor J, Decruyenaere J, Demeyere K, Nuytinck L, Hoste EA, Meyer E. Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients. Crit Care. 2016;20:38.","journal-title":"Crit Care"},{"issue":"1","key":"6203_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.kint.2017.07.010","volume":"93","author":"G Lorenz","year":"2018","unstructured":"Lorenz G, Schmalenberg M, Kemmner S, Haller B, Steubl D, Pham D, Schreiegg A, Bachmann Q, Schmidt A, Haderer S, Huber M, Angermann S, G\u00fcnthner R, Braunisch M, Hauser C, Reichelt AL, Matschkal J, Suttmann Y, Moog P, Stock K, K\u00fcchle C, Th\u00fcrmel K, Renders L, Bauer A, Baumann M, Heemann U, Luppa PB, Schmaderer C. Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation. Kidney Int. 2018;93(1):221\u201330.","journal-title":"Kidney Int"},{"issue":"2","key":"6203_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1681\/ASN.2012060579","volume":"24","author":"IM Schmidt","year":"2013","unstructured":"Schmidt IM, Hall IE, Kale S, Lee S, He CH, Lee Y, Chupp GL, Moeckel GW, Lee CG, Elias JA, Parikh CR, Cantley LG. Chitinase-like protein Brp-39\/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function. J Am Soc Nephrol. 2013;24(2):309\u201319.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"6203_CR50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9343(00)00399-5","volume":"108","author":"CE Fiore","year":"2000","unstructured":"Fiore CE, Pennisi P, Tamborino C. YKL-40 and graft rejection. Am J Med. 2000;108(8):688\u20139.","journal-title":"Am J Med"},{"issue":"3","key":"6203_CR51","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.molimm.2007.07.008","volume":"45","author":"FK Kerr","year":"2008","unstructured":"Kerr FK, Thomas AR, Wijeyewickrema LC, Whisstock JC, Boyd SE, Kaiserman D, Matthews AY, Bird PI, Thielens NM, Rossi V, Pike RN. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor. Mol Immunol. 2008;45(3):670\u20137.","journal-title":"Mol Immunol"},{"issue":"1","key":"6203_CR52","doi-asserted-by":"publisher","first-page":"15464","DOI":"10.1038\/s41598-021-94954-3","volume":"11","author":"E Vonbrunn","year":"2021","unstructured":"Vonbrunn E, Ries T, S\u00f6llner S, M\u00fcller-Deile J, B\u00fcttner-Herold M, Amann K, Daniel C. Multiplex gene analysis reveals T-cell and antibody-mediated rejection-specific upregulation of complement in renal transplants. Sci Rep. 2021;11(1):15464.","journal-title":"Sci Rep"},{"key":"6203_CR53","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3389\/fimmu.2018.02310","volume":"9","author":"M Cernoch","year":"2018","unstructured":"Cernoch M, Hruba P, Kollar M, Mrazova P, Stranavova L, Lodererova A, Honsova E, Viklicky O. Intrarenal complement system transcripts in chronic antibody-mediated rejection and recurrent IgA nephropathy in kidney transplantation. Front Immunol. 2018;9:2310.","journal-title":"Front Immunol"},{"issue":"1","key":"6203_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-022-00567-1","volume":"37","author":"E Vonbrunn","year":"2023","unstructured":"Vonbrunn E, B\u00fcttner-Herold M, Amann K, Daniel C. Complement inhibition in kidney transplantation: where are we now? BioDrugs. 2023;37(1):5\u201319.","journal-title":"BioDrugs"},{"issue":"2","key":"6203_CR55","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7150\/ijbs.37781","volume":"16","author":"KR Park","year":"2020","unstructured":"Park KR, Yun HM, Hong JT. G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway. Int J Biol Sci. 2020;16(2):330\u201341.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"6203_CR56","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/1878-0261.13138","volume":"16","author":"YS Lee","year":"2022","unstructured":"Lee YS, Yu JE, Kim KC, Lee DH, Son DJ, Lee HP, Jung JK, Kim ND, Ham YW, Yun J, Han SB, Hong JT. A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13R\u03b12-mediated JNK-AP-1 signals. Mol Oncol. 2022;16(2):508\u201326.","journal-title":"Mol Oncol"},{"key":"6203_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/TP.0000000000000592","volume":"99","author":"D Viglietti","year":"2015","unstructured":"Vo AA, Zeevi A, Choi J, Cisneros K, Toyoda M, Kahwaji J, Peng A, Villicana R, Puliyanda D, Reinsmoen N, Haas M, Jordan SC. A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. Transplantation. 2015;99:299\u2013308","journal-title":"Transplantation"},{"issue":"15","key":"6203_CR58","first-page":"1596","volume":"16","author":"RA Montgomery","year":"2016","unstructured":"Viglietti D, Gosset C, Loupy A, Deville L, Verine J, Zeevi A, Glotz D, Lefaucheur C. C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study. Am J Transplant. 2016 May;16(5):1596-603","journal-title":"Am J Transpl"},{"key":"6203_CR59","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1111\/ajt.13871","volume":"16","author":"AA Vo","year":"2016","unstructured":"Montgomery RA, Orandi BJ, Racusen L, Jackson AM, Garonzik-Wang JM, Shah T, Woodle ES, Sommerer C, Fitts D, Rockich K, Zhang P, Uknis ME. Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. Am J Transplant. 2016 Dec;16(12):3468-3478","journal-title":"Am J Transplant"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06203-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06203-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06203-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:09:58Z","timestamp":1740042598000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06203-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6203"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06203-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the latest version of the Declaration of Helsinki and was approved by the local ethics committee of Policlinico di Bari (Prot. N. 670\/C.E.).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}